Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis
Top Cited Papers
- 1 April 2008
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 135 (4) , 799-808
- https://doi.org/10.1016/j.jtcvs.2007.07.071
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Neuroprotection by Hypoxic Preconditioning Involves Oxidative Stress-Mediated Expression of Hypoxia-Inducible Factor and ErythropoietinStroke, 2005
- Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia ModelCirculation, 2005
- Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trialThe Lancet, 2004
- Role of Akt Signaling in Mitochondrial Survival Pathway Triggered by Hypoxic PreconditioningCirculation, 2004
- Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiationNature Medicine, 2004
- Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine HeartCirculation, 2002
- Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death StrategiesJournal of Molecular and Cellular Cardiology, 2001
- Bone marrow cells regenerate infarcted myocardiumNature, 2001
- Angiogenesis Induced by the Implantation of Self-Bone Marrow Cells: A New Material for Therapeutic AngiogenesisCell Transplantation, 2000
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999